Advances in metabolomics using untargeted IC-MS

Significance of the topic

Ion chromatography coupled to high-resolution accurate-mass mass spectrometry (IC-MS) addresses a major analytical gap in untargeted metabolomics: robust, reproducible detection and identification of ionic and highly polar metabolites that dominate central carbon, nucleotide, and carbohydrate metabolism. Reliable coverage of these species is critical for understanding disease mechanisms (cancer, metabolic disorders, infections, immune responses), discovering biomarkers, and mapping pathway-level changes that are often missed by conventional separations such as HILIC, IP-MS, or derivatized GC-MS.

Objectives and overview of the study

The case study describes how the McCullagh Group at the University of Oxford implemented Thermo Scientific IC-MS technology to expand untargeted metabolomics discovery. Key aims were to obtain broader metabolome coverage for polar/ionic compounds, improve analytical reproducibility (particularly retention-time stability), and increase confidence in metabolite annotation by combining chromatographic selectivity with HRAM MS and MS/MS data. The group evaluated IC-MS performance relative to HILIC-MS, applied the method across diverse biological samples, and used outcomes to drive collaborations and biological discoveries.

Methodology

The approach prioritized an untargeted 40-minute IC-MS method run continuously across many sample types (cell and tissue extracts) to maximize pathway-relevant coverage. Analytical workflow elements included:

• Reagent-Free IC eluent generation and electrolytic suppressors to produce electrospray-compatible effluent without manual mobile-phase preparation.
• Ion-exchange chromatography to separate anionic and highly polar metabolites with high structural selectivity and retention-time reproducibility.
• High-resolution accurate-mass MS and data-dependent MS/MS acquisition to enable molecular-formula prediction and structural annotation.
• Continuous quality-control sample monitoring and multivariate analysis (e.g., PCA) to assess analytical reproducibility and group separation.

Used instrumentation

The case study explicitly reports the following instrumentation and capabilities:

• Thermo Scientific Dionex ICS-5000+ Ion Chromatography System (RFIC with automated eluent generation and electrolytic suppressor).
• Thermo Scientific Q Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer for HRAM MS and MS/MS.
• Thermo Scientific Dionex ICS-6000 HPIC System paired with Thermo Scientific Orbitrap Exploris 240 Mass Spectrometer (higher resolution, faster scan speed) used to expand throughput and enable AcquireX intelligent acquisition workflows.
• Thermo Scientific Reagent-Free IC (RFIC-EG) capability for automated eluent generation and improved reproducibility and sensitivity.

Main results and discussion

• Expanded coverage: IC-MS provided substantially broader detection of ionic and polar metabolites than HILIC-MS. This translated into improved representation of primary metabolic pathways in untargeted experiments.
• Superior retention-time stability: Over months of continuous operation IC-MS achieved retention-time reproducibility on the order of a few seconds for standards, outperforming HILIC and enabling confident alignment across large sample sets.
• High-confidence annotation: Combining IC retention behavior, HRAM accurate-mass and isotope patterns, and MS/MS fragmentation narrowed structural possibilities and frequently resolved isomers that are challenging by MS alone.
• Operational robustness: RFIC automated eluent generation removed manual mobile-phase variability, and ion-exchange columns demonstrated long lifetimes under heavy sample throughput (columns lasting months to a year of continuous use reported).
• Biological discoveries: IC-MS enabled concrete findings across collaborations, including altered metabolites in IDH1-mutant glioma (elevated 2-hydroxyglutarate, depleted 2-oxoglutarate, and changes in lysine and tryptophan metabolism), roles of autophagy in neutrophil differentiation, plasma biomarkers for intrahepatic cholangiocarcinoma, links between glucose metabolism and HTLV-1 latency, and butyrate-driven antimicrobial programs in macrophages.
• Instrument advances: Use of the Orbitrap Exploris 240 and AcquireX workflows promises improved MS2 coverage, greater mass resolution and scan speed, facilitating deeper untargeted profiling and more efficient identification workflows.

Benefits and practical applications

IC-MS offers several practical advantages for untargeted metabolomics and routine laboratory workflows:

• Comprehensive, pathway-relevant coverage of ionic and polar metabolites in a single, reproducible method without derivatization.
• High retention-time stability suitable for large-scale studies, longitudinal sampling, and standard-based identification strategies.
• Reduced manual error and higher day-to-day consistency via reagent-free eluent generation.
• Compatibility with HRAM MS and MS/MS for confident molecular-formula assignment and structural characterization, improving biomarker discovery and mechanistic studies.
• Applicability across many sample types, enabling cross-project reuse of a standardized method to increase throughput and comparability.

Future trends and potential applications

• Integration with multi-omics: Combining IC-MS metabolite profiles with proteomics and genomics to develop multi-modal biomarkers and systems-level insights.
• Fluxomics and isotopic tracer studies: Application of IC-MS to isotopic tracing to map central carbon fluxes with improved fidelity due to retention stability and HRAM detection.
• Advanced acquisition and informatics: Wider adoption of intelligent acquisition (e.g., AcquireX), faster Orbitrap platforms, and automated MS2 strategies to increase depth of coverage and reduce manual curation.
• Machine learning and spectral libraries: Development of retention-time-aware spectral libraries and machine-learning models to accelerate annotation of polar metabolites and resolve isomers.
• Standardization and throughput: Further standardization of RFIC workflows, robust column chemistries, and automation to scale untargeted studies for clinical and large-cohort applications.

Conclusion

IC-MS combining reagent-free ion chromatography with HRAM MS addresses key limitations of traditional separations for untargeted metabolomics by providing broad, reproducible coverage of ionic and highly polar metabolites with strong retention-time stability and high-confidence annotation potential. The approach has proven productive in diverse biological studies, enabling pathway-centric discoveries and supporting growing laboratory throughput. Advances in instrument speed, intelligent acquisition, and informatics promise to further increase the utility of IC-MS for discovery, flux analysis, and translational biomarker development.

References

The source provides the following primary references relevant to the case study findings:

1. Walsby-Tickle, J.; et al. Anion-exchange chromatography mass spectrometry provides extensive coverage of primary metabolic pathways revealing altered metabolism in IDH1 mutant cells. Communications Biology. 2020, 3 (1), 1-12.
2. Riffelmacher, T.; et al. Autophagy-dependent generation of free fatty acids is critical for normal neutrophil differentiation. Immunity. 2017, 47 (3), 466-480.e5.
3. Winter, H.; et al. Identification of circulating genomic and metabolic biomarkers in intrahepatic cholangiocarcinoma. Cancers. 2019, 11 (12), 1895.
4. Kulkarni, A.; et al. Glucose metabolism and oxygen availability govern reactivation of the latent human retrovirus HTLV-1. Cell Chemical Biology. 2017, 24 (11), 1377-1387.e3.
5. Schulthess, J.; et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity. 2019, 50 (2), 432-445.e7.